文献速递慢性肾脏病肾小球疾病遗传性与小管间质肾病

APOL1肾病风险等位基因与非裔美国成人死亡率:队列研究

APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.
PubMed 文献 · Am J Kidney Dis · 2019-09-26

该前瞻性队列研究纳入REGARDS研究中10,380名非裔美国人和17,485名白人美国参与者,探讨APOL1肾病风险等位基因与全因及病因特异性死亡率的关联。主要结论为:在包含遗传 ancestry 的多变量调整模型中,具有高危APOL1基因型的非裔美国人死亡率低于低危基因型者。

要点

  • 高危APOL1基因型(2个风险等位基因)与低危基因型(0/1个)相比,全因死亡率在基础调整模型中无显著关联(HR 0.88, 95%CI 0.77-1.01)。
  • 进一步调整遗传 ancestry 后,高危基因型与较低的全因死亡率显著相关(HR 0.81, 95%CI 0.69-0.96)。
  • 关联因CKD状态而异(交互作用P=0.04):合并CKD者中高危基因型死亡率更低(HR 0.78, 95%CI 0.62-0.99),无CKD者中无显著差异。

核心结论

  • 在包含遗传 ancestry 的多变量调整模型中,具有高危APOL1基因型的非裔美国人死亡率低于低危基因型者。

研究设计与样本

  • 前瞻性队列研究,纳入REGARDS研究中10,380名非裔美国人和17,485名白人美国参与者。

主要发现

  • 高危APOL1参与者更年轻且白蛋白尿患病率更高。
  • 基础调整模型(社会人口学、合并症、肾功能)中,高危 vs 低危基因型与全因死亡率无显著关联(HR 0.88, 95%CI 0.77-1.01)。
  • 进一步调整遗传 ancestry 后,关联显著(HR 0.81, 95%CI 0.69-0.96)。
  • 关联因CKD状态而异(P交互=0.04):合并CKD者中高危基因型死亡率更低(HR 0.78, 95%CI 0.62-0.99),无CKD者中无显著差异(HR 0.84, 95%CI 0.66-1.05)。
  • 与白人美国人相比,高危基因型非裔美国人死亡率相似,而低危基因型非裔美国人死亡率更高(HR 1.07, 95%CI 1.00-1.14)。

临床怎么用

  • 在评估非裔美国人APOL1高危基因型者的死亡风险时,需考虑CKD状态及遗传 ancestry 的调整。
  • 高危基因型合并CKD者死亡率较低的风险估计需谨慎解读,因缺乏随访肾功能指标。

局限性

  • 缺乏随访期间的肾功能测量指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: APOL1 nephropathy risk alleles are associated with the development of chronic kidney disease (CKD) in African Americans. Although CKD is an established risk factor for mortality, associations of APOL1 risk alleles with mortality are uncertain. STUDY DESIGN: Prospective cohort. SETTINGS & PARTICIPANTS: 10,380 African American and 17,485 white American participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. EXPOSURES: APOL1 nephropathy risk alleles. OUTCOMES: All-cause and cause-specific mortality. ANALYTICAL APPROACH: Cox proportional hazards models were used to examine the association of APOL1 high-risk genotypes (2 risk alleles) versus APOL1 low-risk genotypes (0/1 risk allele) with all-cause and cause-specific mortality in African Americans and examine the risk for all-cause mortality in African Americans with high-risk genotypes versus African Americans with low-risk genotypes and white Americans. RESULTS: APOL1 high-risk participants were younger and had a higher prevalence of albuminuria than low-risk participants. There was no statistically significant association of APOL1 high- versus low-risk genotypes with all-cause mortality in models adjusted for sociodemographic variables, comorbid conditions, and kidney function (HR, 0.88; 95% CI, 0.77-1.01). After further adjustment for genetic ancestry in a subset with available data, a statistically significant association emerged (HR, 0.81; 95% CI, 0.69-0.96). Associations differed by CKD status (Pinteraction=0.04), with African Americans with high-risk genotypes having lower risk for mortality than those with low-risk genotypes in fully adjusted models (HR, 0.78; 95% CI, 0.62-0.99) among those with CKD, but not those without CKD (HR, 0.84; 95% CI, 0.66-1.05). Compared with white Americans, African Americans with high-risk genotypes had a similar rate of mortality, whereas African Americans with low-risk genotypes had a higher rate of mortality (HR, 1.07; 95% CI, 1.00-1.14) in fully adjusted models. LIMITATIONS: Lack of follow-up measures of kidney function. CONCLUSIONS: African Americans with high-risk APOL1 genotypes had lower mortality than those with low-risk genotypes in multivariable-adjusted models including genetic ancestry.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Gutiérrez OM, Irvin MR, Zakai NA, et al. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study. Am J Kidney Dis. 2019. PMID: 31563468. doi:10.1053/j.ajkd.2019.05.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。